Výsledky vyhledávání - "M C, Berchier"

A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party

Autor: J P, Sculier, M, Paesmans, J, Thiriaux, J, Lecomte, G, Bureau, V, Giner, G, Koumakis, J J, Lafitte, M C, Berchier, C G, Alexopoulos, C, Zacharias, P, Mommen, V, Ninane, J, Klastersky

Publikováno v: European journal of cancer (Oxford, England : 1990). 35(9)

We retrospectively analysed the data obtained in a large randomised trial performed in 505 eligible patients with advanced non-small cell lung cancer. Its purpose had been to compare a combination of carboplatin (200 mg/m2) and cisplatin (60 mg/m2) w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4206944f6b6fc2848f54b9aef670e094
https://pubmed.ncbi.nlm.nih.gov/10658520

Zobrazit plný text záznamu

Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party

Autor: J P, Sculier, M, Paesmans, V, Ninane, V, Giner, G, Bureau, J J, Lafitte, J, Baumöhl, J, Thiriaux, O, van Cutsem, P, Recloux, M C, Berchier, C, Zacharias, P, Mommen, P, van Houtte, J, Klastersky

Publikováno v: Lung cancer (Amsterdam, Netherlands). 22(3)

This study attempted to investigate, in a cohort of patients with clinical stage III initially unresectable non-small cell lung cancer (NSCLC) treated by the same induction chemotherapy regimen, the prognostic value of clinical T and N sub-groupings

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b85db63c7d9472723e98d6a18e415673
https://pubmed.ncbi.nlm.nih.gov/10048473

Zobrazit plný text záznamu

[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]

Autor: J P, Sculier, M, Paesmans, P, Libert, G, Bureau, G, Dabouis, J, Thiriaux, J, Michel, O, Van Cutsem, J, Schmerber, V, Giner, M C, Berchier, P, Mommen, R, Sergysels, J, Klastersky

Publikováno v: Revue des maladies respiratoires. 14(6)

The European Lung Cancer Working Party has investigated prognostic factors for response, overall survival, long term survival in a population with advanced non small cell lung cancer registered in a clinical trial evaluating platinum derivatives-cont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5fa54f01adf94b3d1b9e2881d1406f89
https://pubmed.ncbi.nlm.nih.gov/9496602

Zobrazit plný text záznamu

Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party

Autor: J P, Sculier, G, Bureau, V, Giner, J, Thiriaux, J, Michel, M C, Berchier, O, Van Cutsem, U, Küstner, F, Kroll, P, Mommen

Publikováno v: Seminars in oncology. 22(1 Suppl 2)

Prospective trials comparing drug analogues in the treatment of small cell lung cancer are rare. The European Lung Cancer Working Party has conducted a randomized trial with a primary end point of determining the effect on survival of maintenance che

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d76be21c103aee47b8303fe1e15d6b00
https://pubmed.ncbi.nlm.nih.gov/7846537

Zobrazit plný text záznamu

A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working Party

Autor: J, Klastersky, J P, Sculier, F, Ries, G, Dabouis, P, Libert, J, Schmerber, J, Thiriaux, M C, Berchier, G, Bureau, O, Van Cutsem

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 5(7)

To determine in patients with advanced non-small cell lung cancer the activity of a 4-drug combination chemotherapy.Chemotherapy consisted of the administration of cisplatin (30 mg/m2 d 1-3 or 4), mitomycin C (10 mg/m2 d 1), vindesine (3 mg/m2 d 1) a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::deaf2527cffb013c4c417e61e8469364
https://pubmed.ncbi.nlm.nih.gov/7993841

Zobrazit plný text záznamu

[Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party]

Autor: J P, Sculier, M, Paesmans, G, Bureau, G, Dabouis, P, Libert, G, Vandermoten, O, Van Cutsem, M C, Berchier, F, Ries, J, Michel

Publikováno v: Revue des maladies respiratoires. 11(3)

The administration of multiple cytostatic drugs on a weekly basis has been proposed as a new intensive chemotherapy modality for small-cell lung cancer. The European Lung Cancer Working Party has conducted a randomized trial comparing to a standard r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a2c53f32ffdfebaab683b93cc09cb8f5
https://pubmed.ncbi.nlm.nih.gov/8041988

Zobrazit plný text záznamu

Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer

Autor: J J, Body, M, Paesmans, J P, Sculier, G, Dabouis, G, Bureau, P, Libert, M C, Berchier, N, Raymakers, J, Klastersky

Publikováno v: Clinical chemistry. 38(5)

Neuron-specific enolase (NSE) is the most sensitive and specific tumor marker for small-cell lung cancer (SCLC). We evaluated a new monoclonal IRMA (Sangtec) for NSE and compared it with a polyclonal RIA (Pharmacia) in patients with SCLC or other lun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fbce1dea4fc3e06927e8d6433fb7dd9f
https://pubmed.ncbi.nlm.nih.gov/1316245

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání